Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen

Journal of Infection

Volumn 65, Issue 2, 2012, Pages 157-164

  Kaech, Chloe ^a   Pache, Isabelle ^a   Bürgisser, Philippe ^a   Elzi, Luigia ^b   Darling, Katharine E A ^a   Cavassini, Matthias ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Duration of immunity; Hepatitis B vaccination; HIV; Isolated anti HBc

Indexed keywords

ALANINE AMINOTRANSFERASE; ENGERIX B 20; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY ISOLATION; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION PREVENTION; MALE; MIXED INFECTION; PREDICTION; TREATMENT DURATION; VACCINATION; VIREMIA; VIRUS IMMUNITY; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84863006006     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.03.009     Document Type: Article

References (28)

1. Puoti M., Airoldi M., Bruno R., Zanini B., Spinetti A., Pezzoli C., et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 2002, 4(1):27-35.
2. Kellerman S.E., Hanson D.L., McNaghten A.D., Fleming P.L. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003, 188(4):571-577.
3. Rodriguez-Mendez M., Gonzalez-Quintela A., Aguilera A., Barrio E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol 2000, 95(5):1316-1322.
4. Grob P., Jilg W., Bornhak H., Gerken G., Gerlich W., Günter S., et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000, 62(4):450-455.
5. Neau D., Winnock M., Jouvencel A.C., Faure M., Castera L., Legrand E., et al. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005, 40(5):750-753.
6. Santos E.A., Yoshida C.F., Rolla V.C., Mendes J.M., Vieira I.F., Arabe J., et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003, 22(2):92-98.
7. Shire N.J., Rouster S.D., Rajicic N., Sherman K.E. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr: JAIDS 2004, 36(3):869-875.
8. Davaro R.E., Cheeseman S.H., Keroack M.A., Ellison R.T. The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus. Clin Infect Dis 1996, 23(1):189-190.
9. Vazquez-Vizoso F., Eiroa P., Ledo L., Anibarro L., Hernandéz M., Ojea R., et al. HIV infection and isolated detection of anti-HBc. Gastroenterology 1994, 106(3):823-824.
10. Brechot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely ' occult' ?. Hepatology 2001, 34(1):194-203.
11. Torbenson M., Thomas D.L. Occult hepatitis B. Lancet Infect Dis 2002, 2(8):479-486.
12. Raimondo G., Pollicino T., Cacciola I., Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007, 46(1):160-170.
13. Aoki S.K., Finegold D., Kuramoto I.K., Douville C., Richards C., Randell R., et al. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion 1993, 33(5):362-367.
14. McMahon B.J., Parkinson A.J., Helminiak C., Wainwright R.B., Bulkow L., Kellerman-Douglas A., et al. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992, 103(2):590-594.
15. Schifman R.B., Rivers S.L., Sampliner R.E., Krammes J.E. Significance of isolated hepatitis B core antibody in blood donors. Arch Int Med 1993, 153(19):2261-2266.
16. Soriano V., Puoti M., Peters M., Benhamou Y., Sulkowski M., Zoulim F., et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 2008, 22(12):1399-1410.
17. Lok A.S.F., Lai C.-L., Wu P.-C. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988, 8(4):766-770.
18. West D.J., Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996, 14(11):1019-1027.
19. Gandhi R.T., Wurcel A., Lee H., McGovern B., Shopis J., Geary M., et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Inf Dis 2005, 191(9):1435-1441.
20. Chakvetadze C., Bani-Sadr F., Le Pendeven C., Lescure F.X., Fontaine C., Galperine T., et al. Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen. Clin Inf Dis 2010, 50(8):1184-1186.
21. Swiss HIV Cohort Study Schoeni-Affolter F., Ledergerber B., Rickenbach M., Rudin C., Günthard H.F., Telenti A., et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol. 2010, 39(5):1179-1189.
22. Foucher J., Chanteloup E., Vergniol J., Castéra L., Le Bail B., Adhoute X., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006, 55(3):403-408.
23. Hofer M., Joller-Jemelka H.I., Grob P.J., Luthy R., Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998, 17(1):6-13.
24. Rompalo A.M., Cannon R.O., Quinn T.C., Hook E.W. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis 1992, 165(6):1124-1126.
25. Clifford B.D., Donahue D., Smith L., Cable E., Luttig B., Manns M., et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995, 21(3):613-619.
26. Zanetti A.R., Mariano A., Romano L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005, 366(9494):1379-1384.
27. French A.L., Lin M.Y., Evans C.T., Benning L., Glesby M.J., Young M.A., et al. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis 2009, 49:148-154.
28. Koene R.P.M., Gotz H.M., Van den Hoek J.A.R., Heijnen M.L.A., Van Steenbergen J.A., Kroes A.C.M. Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups. Epidemiol Infect 2009, 137:495-503.